acut
respiratori
infect
ari
remain
lead
caus
global
burden
diseas
second
common
caus
ill
worldwid
annual
global
incid
exceed
million
prerequisit
public
health
plan
reduc
global
diseas
burden
ari
examin
data
epidemiolog
order
better
defin
environment
factor
well
target
popul
prevent
intervent
respiratori
virus
predomin
caus
ari
epidemiolog
acut
viral
respiratori
ill
develop
countri
temper
climat
wellcharacter
countri
unit
state
children
shown
carri
larg
burden
viral
respiratori
diseas
recent
prospect
studi
util
sensit
method
detect
respiratori
virus
multiplex
polymeras
chain
reaction
pcr
similarli
demonstr
highest
rate
viral
respiratori
infect
occur
among
children
frequenc
infect
tend
decreas
age
due
increas
acquir
immun
respiratori
syncyti
viru
rsv
influenza
viru
parainfluenza
viru
rhinoviru
long
identifi
common
caus
ari
recent
improv
molecular
detect
techniqu
allow
identif
multipl
new
respiratori
virus
human
metapneumoviru
hmpv
human
bocaviru
hbov
human
coronaviru
bodi
literatur
describ
epidemiolog
acut
viral
respiratori
diseas
develop
countri
rapidli
expand
knowledg
distribut
diseas
region
tropic
south
america
remain
limit
influenza
virus
among
impact
acut
respiratori
pathogen
term
morbid
mortal
despit
develop
public
health
intervent
program
estim
annual
averag
number
influenzarel
hospit
unit
state
exce
death
attribut
influenza
infect
yearli
inform
contribut
influenza
virus
global
burden
diseas
due
acut
respiratori
ill
incomplet
data
epidemiolog
influenza
virus
develop
countri
deriv
multipl
sourc
includ
laboratorybas
surveil
sentinel
surveil
well
hospit
outpati
record
develop
countri
resourc
spars
sentinel
surveil
method
may
readili
access
costeffect
laboratorybas
populationbas
surveil
determin
viral
etiolog
influenzalik
ill
ili
region
better
identif
viral
caus
ili
enabl
clinician
resourcelimit
set
appropri
treat
manag
patient
importantli
allow
public
health
offici
formul
effect
prevent
control
strategi
includ
monitor
influenza
vaccin
efficaci
commun
studi
epidemiolog
ili
tropic
south
central
american
countri
peru
brazil
ecuador
nicaragua
hondura
el
salvador
publish
prospect
studi
adult
ili
sao
paulo
brazil
reveal
influenza
virus
predomin
caus
ili
rhinovirus
respiratori
virus
detect
subject
respect
observ
illustr
signific
proport
patient
clinic
diagnos
influenza
viru
infect
may
symptom
indistinguish
respiratori
virus
prospect
studi
ili
ecuador
region
distribut
influenza
viru
infect
vari
higher
detect
rate
influenza
occur
quito
locat
highland
level
absolut
humid
lower
wherea
influenza
detect
rate
lower
coastal
citi
guayaquil
humid
tropic
climat
addit
expand
sentinel
surveil
ili
conduct
health
center
hospit
locat
peruvian
citi
show
distribut
ilicaus
virus
vari
region
studi
illustr
import
conduct
baselin
continu
ili
surveil
countri
central
south
america
ili
caus
pathogen
influenza
virus
distribut
respiratori
infect
may
vari
within
region
within
particular
countri
depend
climat
topographi
venezuela
ari
primari
caus
weekli
notifi
diseas
regist
nation
epidemiolog
surveil
system
ness
nonetheless
low
number
respiratori
sampl
collect
even
lower
number
confirm
nation
system
virolog
surveil
ari
furthermor
epidemiolog
clinic
characterist
viral
caus
ili
poorli
character
venezuela
knowledg
one
longitudin
studi
carri
limit
period
time
februari
low
number
patient
n
ari
publish
object
paper
describ
epidemiolog
ili
use
data
sentinel
surveil
system
two
major
hospit
maracay
venezuela
total
subject
particip
studi
six
hundr
thirti
seven
recruit
hospit
central
de
maracay
hcm
slightli
larger
proport
femal
compar
male
enrol
studi
vs
gender
distribut
two
site
similar
subject
age
rang
month
year
mean
age
year
sd
year
median
year
signific
percentag
subject
year
age
less
year
older
year
old
group
predomin
group
compris
studi
popul
follow
year
old
age
group
subject
present
hcm
significantli
older
mean
age
year
sd
year
compar
seen
hospit
del
instituto
venezolano
de
lo
seguro
social
jose
maria
carabano
tosta
ivssjmct
mean
age
year
sd
year
larg
proport
subject
hcm
belong
age
group
nearli
half
patient
seen
ivssjmct
younger
year
old
approxim
subject
report
receiv
influenza
vaccin
within
last
year
small
percentag
patient
receiv
antibiot
treatment
acut
respiratori
ill
prior
enrol
studi
hospit
case
ili
recruit
studi
outpati
subject
particip
demograph
inform
summar
tabl
among
patient
sampl
obtain
sentinel
surveil
least
one
viral
organ
detect
viral
isol
andor
revers
transcriptasepolymeras
chain
reaction
rtpcr
subject
tabl
one
particip
coinfect
observ
influenza
virus
frequent
detect
organ
passiv
surveil
consist
virus
detect
viral
isol
andor
rtpcr
sampl
collect
posit
influenza
virus
influenza
b
virus
viral
isol
andor
rtpcr
addit
noninfluenza
virus
detect
viru
isol
adenoviru
parainfluenza
viru
rsv
virus
includ
hbov
enteroviru
hmpv
rhinoviru
herp
simplex
viru
hsv
coinfect
observ
month
old
toddler
adenoviru
hsv
isol
viru
etiolog
detect
rate
vari
age
tabl
commonli
detect
viral
pathogen
year
old
group
influenza
adenovirus
influenza
b
commonli
detect
virus
schoolag
group
year
old
respect
late
adolesc
young
adult
group
yearold
respect
influenza
detect
viru
among
patient
year
older
influenza
case
subtyp
detect
observ
age
group
subject
age
year
old
tabl
six
case
subtyp
nonpandem
influenza
virus
isol
subtyp
onestep
rtpcr
latter
classifi
season
isol
patient
sampl
collect
start
pandem
outbreak
twentyon
case
pandem
influenza
viru
infect
identifi
sentinel
surveil
thirteen
occur
year
old
group
case
infect
among
adult
year
old
higher
genet
analysi
base
partial
hemagglutinin
gene
sequenc
approxim
bp
influenza
isol
shown
figur
see
materi
method
genbank
access
number
analysi
show
circul
season
strain
venezuela
figur
similar
one
previous
describ
central
south
america
sampl
group
like
genotyp
sampl
part
one
cluster
similar
previous
report
strain
latin
america
influenza
sampl
possess
genet
variabl
figur
isol
reveal
two
genotyp
recent
isol
closer
genotyp
final
figur
genet
analysi
influenza
b
isol
disclos
presenc
two
differ
genotyp
agreement
previous
found
region
figur
illustr
tempor
distribut
ili
viral
etiolog
ili
respect
octob
decemb
ili
observ
throughout
year
irregular
peak
activ
occur
twice
annual
month
june
januari
januari
octob
june
figur
pattern
influenza
occurr
variabl
year
year
figur
influenza
viru
detect
everi
month
everi
year
observ
month
period
month
respect
lower
influenza
activ
observ
detect
month
januari
march
septemb
occurr
peak
ili
activ
correl
detect
influenza
viru
subject
respiratori
sampl
month
see
figur
peak
influenza
b
viru
activ
detect
januari
decemb
adenoviru
detect
frequent
decemb
april
rsv
infect
occur
frequent
june
novemb
parainfluenza
virus
detect
throughout
year
without
distinct
season
passiv
surveil
illustr
impact
distribut
respiratori
virus
associ
ili
figur
ili
peak
percentag
ili
case
attribut
influenza
virus
rang
first
case
surveil
system
detect
juli
three
month
swine
origin
influenza
outbreak
began
mexico
first
wave
juli
monthli
viru
detect
rate
rose
virus
detect
pandem
strain
first
wave
simul
typic
ili
peak
activ
similar
observ
year
howev
larger
second
wave
octob
viru
posit
rate
exceed
pandem
strain
identifi
greater
virus
detect
figur
demonstr
complet
replac
season
influenza
virus
peak
pandem
activ
octob
follow
rapid
declin
rate
pandem
strain
detect
one
month
later
meanwhil
season
influenza
virus
remain
circul
throughout
pandem
period
compris
influenza
virus
detect
octob
influenza
specimen
obtain
via
oropharyng
swab
randomli
select
test
pandem
strain
via
rtpcr
case
detect
figur
howev
season
influenza
continu
detect
surveil
system
monthli
posit
rate
rang
clinic
featur
subject
surveil
summar
tabl
compar
whose
respiratori
secret
test
neg
subject
viru
identifi
like
sore
throat
headach
pharyng
congest
ear
pain
signific
differ
symptom
individu
season
influenza
compar
suffer
influenza
except
higher
proport
latter
subject
expector
myalgia
lymphadenopathi
symptom
influenza
either
season
pandem
influenza
b
clinic
indistinguish
compar
patient
ili
due
virus
higher
percentag
confirm
influenza
viru
infect
experienc
sore
throat
myalgia
headach
scarc
inform
epidemiolog
acut
febril
respiratori
ill
venezuela
knowledg
one
longitudin
studi
publish
investig
howev
limit
number
subject
n
recruit
short
period
time
month
describ
transmiss
season
viral
infect
thu
studi
first
fulli
describ
epidemiolog
viral
etiolog
ili
venezuela
provid
baselin
level
ili
activ
typic
highlypopul
urban
citi
studi
demonstr
influenza
virus
main
caus
ili
hcm
ivss
maracay
agreement
find
report
ness
nevertheless
rate
confirm
influenza
viru
infect
found
surveil
tabl
studi
period
lower
one
report
ness
period
differ
detect
rate
may
attribut
differ
strategi
captur
ari
patient
especi
influenza
use
ness
studi
protocol
flore
e
director
epidemiolog
corposalud
person
commun
ness
randomli
select
sampl
ari
case
includ
influenza
emphasi
sever
hospit
case
wherea
protocol
recruit
ili
subject
outpati
set
major
symptom
sever
hand
percentag
influenza
virus
includ
detect
studi
similar
period
time
differ
year
februari
juli
data
shown
much
higher
one
report
valero
et
al
februari
juli
two
caus
may
account
signific
differ
found
studi
collect
preserv
process
respiratori
sampl
b
type
cell
ifa
reagent
use
viru
isol
identif
proport
influenza
case
significantli
differ
compar
nonpandem
pandem
period
pandem
ness
detect
influenza
viru
subject
viru
isol
similar
proport
data
shown
found
studi
height
pandem
juli
dec
ness
confirm
ari
case
viru
either
influenza
b
viru
compar
observ
studi
predomin
influenza
virus
etiolog
agent
ili
maracay
venezuela
consist
observ
surveil
studi
tropic
central
south
american
countri
overal
viru
detect
rate
tabl
lower
compar
studi
posit
rate
influenza
influenza
b
surveil
compar
observ
similar
studi
el
salvador
hondura
nicaragua
find
also
consist
studi
indonesia
identifi
influenza
b
respiratori
sampl
use
viral
isol
rtpcr
find
consist
prospect
studi
outpati
children
northern
taiwan
influenza
b
isol
subject
ili
use
madindarbi
canin
kidney
mdck
cell
cultur
hemagglutinin
inhibit
assay
antigen
detect
howev
detect
rate
respiratori
virus
well
influenza
b
virus
gener
lower
compar
studi
conduct
south
america
expand
sentinel
surveil
studi
peru
util
similar
methodolog
viral
detect
studi
viru
posit
rate
influenza
b
rate
respect
prospect
surveil
studi
ili
two
ecuadorian
citi
use
similar
method
least
one
viru
detect
particip
influenza
detect
pcr
test
posit
influenza
b
lower
viru
detect
rate
found
studi
unclear
use
oper
protocol
describ
mention
studi
nevertheless
differ
skill
collect
respiratori
tract
specimen
ili
patient
health
personnel
employ
studi
may
account
lower
viru
detect
rate
found
studi
influenza
virus
observ
preval
viral
pathogen
adenoviru
parainfluenza
viru
rsv
import
caus
ili
two
hospit
tabl
venezuela
ness
report
rsv
frequent
detect
noninfluenza
respiratori
viru
follow
parainfluenza
viru
rhinoviru
studi
perform
zulia
venezuela
also
report
rsv
common
detect
viru
follow
adenoviru
parainfluenza
viru
influenza
virus
previous
mention
differ
detect
rate
may
attribut
differ
procedur
use
ness
venezuelan
research
us
viral
pathogen
also
frequent
detect
surveil
studi
central
south
america
highest
detect
rate
respiratori
virus
observ
year
old
group
tabl
rate
viral
posit
gener
decreas
age
acquir
immun
increas
older
subject
slight
increas
seen
year
old
group
year
older
group
subject
year
old
older
compris
less
studi
popul
thu
preval
age
group
may
unreli
contrari
studi
studi
venezuela
higher
detect
rate
year
old
group
respect
hand
find
consist
observ
tecumseh
studi
communitybas
surveil
michigan
children
shown
highest
rate
viral
respiratori
diseas
tecumseh
studi
illustr
variabl
impact
influenza
virus
among
differ
age
group
depend
influenza
viru
subtyp
exampl
influenza
affect
wide
rang
age
group
influenza
influenza
b
viru
infect
occur
frequent
among
older
children
young
adult
find
similar
season
influenza
virus
influenza
b
detect
primarili
children
young
adult
season
influenza
found
age
group
expect
common
influenza
subtyp
identifi
among
subject
ili
figur
figur
ili
case
due
detect
rate
lower
detect
rate
report
venezuela
ness
nevertheless
find
similarli
demonstr
respiratori
ill
surveil
network
tropic
temper
south
american
countri
guatemala
peru
argentina
brazil
nonpandem
influenza
virus
continu
circul
venezuela
detect
surveil
studi
suggest
displac
season
influenza
virus
year
ari
case
report
venezuela
ness
due
infect
may
stimul
immun
among
resid
commun
initi
arriv
observ
suggest
circul
may
significantli
mutat
rel
strain
antibodi
stimul
natur
infect
initi
arriv
may
still
highli
effici
protect
commun
anoth
wave
outbreak
infect
rate
influenza
higher
rate
observ
previou
year
illustr
lack
cross
protect
influenza
studi
show
hmpv
hbov
commonli
associ
ili
base
low
detect
rate
observ
surveil
studi
ecuador
util
method
similar
employ
studi
low
detect
rate
hbov
report
latter
studi
well
anoth
central
america
use
method
similar
report
rare
detect
hmpv
contrast
prospect
studi
ili
among
brazilian
adult
util
viral
isol
rtpcr
test
respiratori
sampl
detect
rhinovirus
patient
although
rhinovirus
typic
associ
milder
ill
contribut
misdiagnosi
influenza
base
clinic
case
definit
alon
cohort
studi
vietnames
children
hospit
acut
febril
respiratori
ill
appli
multiplexpcr
assay
respiratori
sampl
reveal
slightli
higher
preval
rate
hbov
hmpv
infect
import
note
method
identif
cultur
three
cell
line
compar
molecular
diagnost
method
substanti
lack
sensit
detect
rhinovirus
hmpv
hbov
studi
show
patient
infect
like
myalgia
product
cough
expector
lymphadenopathi
infect
season
influenza
viru
tabl
contrast
clinic
manifest
guatemalan
subject
hospit
season
influenza
infect
significantli
differ
studi
limit
worth
note
data
collect
two
hospit
urban
area
limit
abil
gener
find
popul
low
viru
detect
rate
may
attribut
variat
skill
health
staff
employ
collect
respiratori
specimen
sampl
method
may
signific
effect
proport
respiratori
virus
identifi
nasopharyng
wash
may
yield
higher
sensit
nasopharyng
oropharyng
swab
studi
particip
exclus
seen
outpati
set
thu
limit
abil
examin
impact
respiratori
virus
hospit
case
larg
proport
ili
case
associ
pathogen
impact
bacteria
clinic
syndrom
determin
studi
sinc
respiratori
sampl
cultur
bacteria
two
method
detect
use
identif
influenza
pcr
cultur
wherea
one
method
detect
use
virus
cultur
twentytwo
percent
respiratori
sampl
posit
influenza
virus
rtpcr
neg
viral
isol
illustr
viral
detect
cultur
underestim
true
preval
viral
cultur
may
ideal
way
isol
organ
rsv
hmpv
hbov
rhinovirus
lead
signific
underestim
detect
rate
despit
limit
studi
contribut
inform
distribut
etiolog
ili
two
hospit
maracay
venezuela
knowledg
serv
baselin
futur
expans
populationbas
surveil
studi
influenza
respiratori
virus
region
maracay
locat
central
northern
region
venezuela
n
w
approxim
mile
caribbean
coast
figur
climat
tropic
two
season
dri
raini
monthli
averag
temperatur
rel
humid
rainfal
rang
rang
mm
rang
mm
respect
maracay
compris
two
main
urban
municip
name
girardot
mario
iragorri
estim
total
popul
hcm
ivssjmct
locat
approxim
mile
apart
major
counti
hospit
referr
health
center
adult
pediatr
depart
includ
emerg
servic
ivssjmct
hcm
hospit
bed
provid
servic
peopl
maracay
well
adjac
citi
aragua
three
neighbor
state
studi
popul
includ
everi
outpati
ili
regardless
age
sought
attent
two
studi
site
octob
decemb
agre
particip
studi
site
train
medic
personnel
respons
properli
identifi
classifi
patient
ili
person
ili
ask
enrol
studi
person
defin
ili
sudden
onset
fever
either
cough
sore
throat
less
five
day
durat
without
gener
symptom
myalgia
prostrat
headach
malais
data
gender
age
previou
treatment
medic
attent
enrol
influenza
vaccin
statu
day
workschool
lost
time
acut
ill
collect
util
case
report
form
crf
particip
met
case
definit
criteria
tempor
distribut
result
record
month
studi
period
take
account
number
ili
case
identifi
number
confirm
case
influenza
b
studi
site
monthli
report
enrol
ili
particip
laboratori
result
sent
venezuelan
ministri
health
regular
personnel
train
protocol
procedur
conduct
part
strategi
improv
sampl
storag
ship
procedur
protocol
approv
less
minim
risk
research
naval
medic
research
center
nmrc
silver
spring
maryland
institut
review
board
irb
protocol
author
given
perform
studi
use
inform
sheet
approv
stamp
irb
part
clinic
care
routin
surveil
benefit
ministri
health
verbal
consent
obtain
particip
method
consent
accept
nmrc
irb
well
venezuelan
institut
involv
verbal
consent
approv
irb
follow
ciom
common
rule
minim
risk
studi
local
health
instal
would
requir
written
consent
procedur
requir
studi
addit
document
includ
inform
written
consent
would
requir
copi
provid
studi
subject
studi
personnel
respons
administ
process
inform
consent
train
site
human
research
protect
issu
certifi
collabor
institut
train
initi
citi
final
frequent
monitor
visit
conduct
studi
team
found
problem
process
complaint
studi
particip
nasal
oropharyng
swab
obtain
subject
viral
isol
identif
swab
place
viral
transport
media
store
deliv
dri
ice
lima
laboratori
analysi
duplic
swab
process
analyz
laboratorio
region
de
diagnostico
e
investigacion
del
dengu
otra
enfermedad
viralesinstituto
de
investigacion
biomedica
de
la
universidad
de
carabobo
lardidevbiomeduc
maracay
venezuela
follow
oper
protocol
use
ninehundr
sixteen
nasal
oropharyng
swab
process
viral
isol
identif
follow
procedur
describ
lagunatorr
et
al
briefli
patient
specimen
inocul
onto
four
cell
line
madindarbi
canin
kidney
mdck
number
african
green
monkey
kidney
number
rhesu
monkey
kidney
number
upon
appear
cytopath
effect
ten
day
cultur
thirteen
day
case
vero
cell
cell
spot
onto
microscop
slide
cell
suspens
dri
fix
chill
aceton
minut
viru
isol
identifi
use
direct
fluoresc
antibodi
dfa
assay
respiratori
viru
screen
identif
kit
dfa
respiratori
viru
diagnost
hybrid
athen
oh
util
identif
adenovirus
influenza
viru
influenza
b
viru
parainfluenza
virus
type
rsv
dfa
herp
simplex
viru
hsv
identif
kit
ifa
enteroviru
id
kit
diagnost
hybrid
athen
oh
util
identif
hsv
enterovirus
respect
isol
hmpv
use
vero
cell
line
detect
hmpv
antigen
direct
fluoresc
assay
use
antihmpv
mous
monoclon
antibodi
diagnost
hybrid
athen
oh
assay
perform
follow
manufactur
instruct
hbov
identifi
use
method
describ
salmonmulanovich
et
al
sinc
duplic
swab
sampl
analyz
differ
laboratori
lardidevbiomeduc
diagnost
kit
standard
oper
procedur
viru
isol
result
consid
posit
specif
viru
isol
identifi
either
site
subset
specimen
nasal
oropharyng
analyz
onestep
rtpcr
andor
real
time
rtpcr
order
subtyp
influenza
includ
influenza
influenza
b
virus
onestep
rtpcr
andor
real
time
rtpcr
use
identifi
noninfluenza
virus
specif
primer
protocol
avail
subtyp
influenza
virus
thu
viru
isol
use
detect
identifi
noninfluenza
virus
specimen
randomli
select
repositori
sampl
collect
pandem
test
influenza
subtyp
onestep
rtpcr
andor
real
time
rtpcr
onset
pandem
respiratori
sampl
test
real
time
rtpcr
request
venezuelan
ministri
health
peak
second
wave
pandem
percentag
respiratori
sampl
test
real
time
rtpcr
reduc
onestep
rtpcr
perform
accord
procedur
influenza
primer
describ
real
time
rtpcr
carri
use
procedur
cdc
protocol
cdc
ref
version
cdc
ref
cdc
ref
version
swine
influenza
materi
provid
influenza
divis
center
diseas
control
prevent
usa
stephen
lindstrom
person
commun
protocol
avail
cdc
upon
request
purpos
studi
ili
case
confirm
viral
respiratori
infect
one
viral
isol
andor
rtpcr
identifi
viru
viral
rna
extract
perform
supernat
infect
mdck
cell
use
qiaamp
viral
rna
kit
qiagen
valencia
ca
follow
manufactur
protocol
onestep
rtpcr
perform
follow
procedur
describ
previous
primer
amplifi
hemagglutinin
ha
gene
influenza
influenza
b
virus
use
superscript
iii
onestep
rtpcr
system
kit
invitrogen
san
diego
ca
follow
primer
use
amplif
influenza
virus
influenza
virus
influenza
b
virus
five
extract
rna
ad
master
mix
contain
enzym
mixtur
superscript
iii
rtplatinum
taq
reaction
mixtur
contain
mm
dntp
mm
primer
cycl
condit
includ
revers
transcript
step
minut
denatur
step
minut
cycl
condit
pcr
cycl
second
second
second
follow
final
incub
step
minut
confirm
serotyp
genotyp
circul
influenza
virus
sampl
sequenc
part
respiratori
surveil
protocol
venezuela
virus
randomli
select
approxim
posit
sampl
ha
gene
region
influenza
virus
analyz
routin
genotyp
onertpcr
product
amplifi
primer
describ
purifi
use
centrisep
column
princeton
separ
englishtown
nj
sequenc
use
bigdy
termin
v
cycl
sequenc
kit
appli
biosystem
foster
citi
ca
follow
manufactur
instruct
sequenc
analyz
edit
use
sequenc
softwar
appli
biosystem
foster
citi
ca
phylogenet
tree
construct
neighborjoin
method
bootstrap
analysi
determin
bestfit
tree
gene
use
mega
softwar
version
statist
signific
tree
topolog
test
bootstrap
replica
pairwis
distanc
within
genotyp
nucleotid
level
calcul
kimura
paramet
poisson
correct
amino
acid
level
mega
softwar
genbank
access
number
list
tabl
inform
crf
enter
databas
creat
microsoft
offic
access
chi
squar
fisher
exact
test
use
compar
mean
associ
use
spss
softwar
version
spss
inc
chicago
il
r
version
r
develop
core
team
vienna
austria
